cancer vaccine

Graphic image of two hands shaking with employeesexecutives on the forearms of each shaking hand
Biotech

TransCode rewrites future, securing $25M and phase 3 vaccine

In a pair of deals, TransCode has bagged a phase 3 cancer vaccine and a $25 million injection into its cash-strapped coffers.
Nick Paul Taylor Oct 8, 2025 11:02am
Layoffs

IO lays off 50% after FDA derails cancer vaccine approval plan

Sep 29, 2025 8:55am
Focus magnify target strategy

Nykode bets future on cancer trial after losing Genentech pact

Aug 27, 2025 8:25am
next step ladder climb succeed win

PDS reports 39 months OS in phase 2 head and neck cancer trial

Aug 25, 2025 9:00am
dart board miss failure

Cancer vaccine's 'narrow' fail won't stop IO heading to FDA

Aug 11, 2025 9:48am
arrow choose one big pick forward many

Scancell picks winner from phase 2 cancer vaccine face-off

Jul 22, 2025 9:38am